Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Russian scientists report on myelopeptides

Sep. 5, 1997

UDCA suppresses allograft rejection after heart transplant

Sep. 3, 1997

Cortecs granted patent for Flustat

Aug. 29, 1997

Cel-Sci reaches supply agreement with American Red Cross

Aug. 26, 1997

Vertex discloses a novel series of ICE inhibitors

Aug. 25, 1997

TNF-alpha inhibitors reported by Centocor

Aug. 21, 1997

Infanrix Hep B approved in all EU countries

Aug. 19, 1997

Twinrix now available for pediatric use

Aug. 18, 1997

IL-1ra tested for corneal transplant

Aug. 7, 1997

Alpha-Beta Technology's Betafectin shows efficacy in phase III trial

Aug. 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...
AI drug developer Insilico to raise $292 million in Hong Kong IPO
BioWorld
Insilico Medicine Inc. plans to raise HK$2.27 billion (US$292 million) in its IPO on the Hong Kong Securities Exchange to advance its clinical pipeline and invest...